Tid Tittel Kategori Vedlegg
29.05.2026
07:00
 Circio Holding ASA Exercise of Warrants by primary insiders INSIDEHANDEL INS -
28.05.2026
07:00
 Circio hosts live webcast today 28 May 2026 at 10:00 am CEST -
1
27.05.2026
07:00
 Circio and AaviGen jointly announce research collaboration to advance novel gene therapies for heart diseases - -
26.05.2026
07:10
 Announcement of the terms of the underwriting and the Unused Warrants Option Agreement in connection with the Warrant Program INFORMASJON INF -
26.05.2026
07:05
 Commencement of exercise period for the Warrants - -
26.05.2026
07:00
 Warrants exercise period commences today potential proceeds to transform Circio into a clinical-stage circular RNA company INFORMASJON INF -
22.05.2026
18:11
 Circio Holding ASA: Exercise price for Warrants set at NOK 8.2508 - -
22.05.2026
07:00
 Circio invites to a live webcast on 28 May 2026 to summarize the presentations at ASGCT 2026 and provide an overview of the warrants program - -
21.05.2026
07:00
 Circio files EPO patent application covering critical aspects of its circVec platform for enhanced gene and cell therapy - -
15.05.2026
22:15
 Circio presents new and extensive circVec data at ASGCT supporting substantial AAV dose reduction INFORMASJON INF
2
11.05.2026
13:29
 Circio Holding ASA: Issuance of restricted stock units (RSUs) to board member -
1
11.05.2026
12:12
 Circio Holding ASA: Registration of share capital increase following exercise of options and settlement of RSUs - -
11.05.2026
11:08
 Circio Holding ASA: Issuance of restricted stock units (RSUs) to the board members -
1
08.05.2026
16:00
 Circio Holding ASA: Minutes from the annual general meeting 2026 -
1
07.05.2026
10:08
 Circio Holding ASA: Mandatory notification of trade by primary insiders pertaining to settlement of RSUs INSIDEHANDEL INS
1
06.05.2026
14:34
 Practical information relating to the warrant program - -
06.05.2026
12:48
 Circio Holding ASA: Exercise of options, settlement of RSUs and resolutions to increase the share capital - -
29.04.2026
07:00
 Circio announces research collaboration with the Universidad de Santiago de Compostela s TraffikGene project to advance non-viral circVec delivery - -
27.04.2026
22:30
 Circio announces publication of two abstracts selected for presentation at the ASGCT annual meeting -
2
24.04.2026
22:00
 Circio announces that the ongoing feasibility study with a major global pharmaceutical corporation is progressing to in vivo testing INFORMASJON INF -
24.04.2026
19:40
 Circio Holding ASA: Cancellation of Subsequent Offering - -
17.04.2026
14:15
 Circio Holding ASA Notice of annual general meeting 2026 -
1
16.04.2026
09:00
 Circio Holding ASA: Annual Report and Remuneration Report for 2025 RAPPORT RAP
4
16.04.2026
07:00
 Mandatory adjustment of RSUs and share options following recently completed rights issue -
1
15.04.2026
07:00
 Circio enters in vivo cell therapy evaluation agreement with Acuitas Therapeutics - -